Featured Research

from universities, journals, and other organizations

Rare skin cancer vaccine: Early stage research begins

Date:
November 5, 2010
Source:
Yorkshire Cancer Research
Summary:
Scientists plan to introduce the genetic material of a virus into normal human skin cells to produce skin cells that have features of Merkel cell carcinoma cancers. They will use these synthetic MCC cancer cells along with real MCC cell patient samples to analyze the reactions of human immune cells against them. The scientists ultimately hope to increase current knowledge about the human body’s ability to eliminate MCC cancer cells to help develop a vaccine in the future.

Leeds-based scientists, funded by Yorkshire Cancer Research headquartered in Harrogate, North Yorkshire, plan to introduce the genetic material of a virus into normal human skin cells to produce skin cells that have features of Merkel Cell Carcinoma cancers.

Researchers at the University of Leeds have taken their first steps towards understanding why a rare skin cancer that is rapidly growing in incidence in Europe and the USA is not recognised by the body's immune system.

Merkel cell carcinoma (MCC) arises from uncontrolled growth of skin cells and usually develops on sun-exposed areas as a firm, painless, red-coloured bump that grows over several weeks to months.

The condition typically develops in people aged 65 and over and those with weakened immune systems and there are currently around 1500 cases a year in the UK with one third of these proving fatal.

During recent research, around 80 percent of MCCs on human skin were shown to contain a virus termed Merkel cell polyomavirus which is believed to be associated with the growth of this cancer.

Now Leeds-based scientists, funded by Yorkshire Cancer Research headquartered in Harrogate, North Yorkshire, plan to introduce the genetic material of this virus into normal human skin cells to produce skin cells that have features of MCC cancers.

They will use these synthetic MCC cancer cells along with real MCC cell patient samples to analyse the reactions of human immune cells against them.

The scientists ultimately hope to increase current knowledge about the human body's ability to eliminate MCC cancer cells to help develop a vaccine in the future.

Professor Eric Blair, who is leading the project, said: "Since a virus is involved in the development of Merkel cell carcinoma skin cancer it is important to understand how the virus prevents the immune system attacking the MCC tumour.

"We are aiming to develop strategies to prevent or eradicate tumours and improve the prognosis of patients who suffer with this terrible skin disease which is currently extremely poor."


Story Source:

The above story is based on materials provided by Yorkshire Cancer Research. Note: Materials may be edited for content and length.


Cite This Page:

Yorkshire Cancer Research. "Rare skin cancer vaccine: Early stage research begins." ScienceDaily. ScienceDaily, 5 November 2010. <www.sciencedaily.com/releases/2010/11/101105085423.htm>.
Yorkshire Cancer Research. (2010, November 5). Rare skin cancer vaccine: Early stage research begins. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2010/11/101105085423.htm
Yorkshire Cancer Research. "Rare skin cancer vaccine: Early stage research begins." ScienceDaily. www.sciencedaily.com/releases/2010/11/101105085423.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins